Skip to Main Content

Author Details

Darawalee Wangsa
Center for Cancer Research, National Cancer Institute
2005
54
21
PMIDPaper TitleJournal TitlePublished Year
36715552Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes.Cancer Discov2023
37095531High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma.J Exp Clin Cancer Res2023
36971511Extrachromosomal Amplification of Human Papillomavirus Episomes Is a Mechanism of Cervical Carcinogenesis.Cancer Res2023
36715691Intratumoral Heterogeneity and Clonal Evolution Induced by HPV Integration.Cancer Discov2023
36715552Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes.Cancer Discov2023
36971511Extrachromosomal Amplification of Human Papillomavirus Episomes Is a Mechanism of Cervical Carcinogenesis.Cancer Res2023
37095531High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma.J Exp Clin Cancer Res2023
36715691Intratumoral Heterogeneity and Clonal Evolution Induced by HPV Integration.Cancer Discov2023
36045282Author Correction: Selective advantage of trisomic human cells cultured in non-standard conditions.Sci Rep2022
36045282Author Correction: Selective advantage of trisomic human cells cultured in non-standard conditions.Sci Rep2022
33402335Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancer.Sci Signal2021
34233304Deterministic assembly of chromosome ensembles in a programmable membrane trap array.Biofabrication2021
33527590Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell lines.Genes Chromosomes Cancer2021
33620383CENP-A overexpression promotes aneuploidy with karyotypic heterogeneity.J Cell Biol2021
34266888Clonal selection of stable aneuploidies in progenitor cells drives high-prevalence tumorigenesis.Genes Dev2021
34034815Hard wiring of normal tissue-specific chromosome-wide gene expression levels is an additional factor driving cancer type-specific aneuploidies.Genome Med2021
33402335Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancer.Sci Signal2021
34569598TP53 loss initiates chromosomal instability in fallopian tube epithelial cells.Dis Model Mech2021
33620383CENP-A overexpression promotes aneuploidy with karyotypic heterogeneity.J Cell Biol2021
33527590Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell lines.Genes Chromosomes Cancer2021
34569598TP53 loss initiates chromosomal instability in fallopian tube epithelial cells.Dis Model Mech2021
34266888Clonal selection of stable aneuploidies in progenitor cells drives high-prevalence tumorigenesis.Genes Dev2021
34034815Hard wiring of normal tissue-specific chromosome-wide gene expression levels is an additional factor driving cancer type-specific aneuploidies.Genome Med2021
34233304Deterministic assembly of chromosome ensembles in a programmable membrane trap array.Biofabrication2021
31570787Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1.Oncogene2020
32259323Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments.Genes Chromosomes Cancer2020
32253233Single-Cell-Derived Primary Rectal Carcinoma Cell Lines Reflect Intratumor Heterogeneity Associated with Treatment Response.Clin Cancer Res2020
32365785Tetraploidy-Associated Genetic Heterogeneity Confers Chemo-Radiotherapy Resistance to Colorectal Cancer Cells.Cancers (Basel)2020
32057297Suppressing proteasome mediated processing of topoisomerase II DNA-protein complexes preserves genome integrity.Elife2020
31570787Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1.Oncogene2020
32057297Suppressing proteasome mediated processing of topoisomerase II DNA-protein complexes preserves genome integrity.Elife2020
32365785Tetraploidy-Associated Genetic Heterogeneity Confers Chemo-Radiotherapy Resistance to Colorectal Cancer Cells.Cancers (Basel)2020
32259323Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments.Genes Chromosomes Cancer2020
32253233Single-Cell-Derived Primary Rectal Carcinoma Cell Lines Reflect Intratumor Heterogeneity Associated with Treatment Response.Clin Cancer Res2020
30909073Single Chromosome Aneuploidy Induces Genome-Wide Perturbation of Nuclear Organization and Gene Expression.Neoplasia2019
30229897Single-cell genetic analysis of clonal dynamics in colorectal adenomas indicates CDX2 gain as a predictor of recurrence.Int J Cancer2019
31174021Induced Chromosomal Aneuploidy Results in Global and Consistent Deregulation of the Transcriptome of Cancer Cells.Neoplasia2019
30909073Single Chromosome Aneuploidy Induces Genome-Wide Perturbation of Nuclear Organization and Gene Expression.Neoplasia2019
30229897Single-cell genetic analysis of clonal dynamics in colorectal adenomas indicates CDX2 gain as a predictor of recurrence.Int J Cancer2019
31174021Induced Chromosomal Aneuploidy Results in Global and Consistent Deregulation of the Transcriptome of Cancer Cells.Neoplasia2019
29452566Near-tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness.FASEB J2018
29979962A Muscle-Specific Enhancer RNA Mediates Cohesin Recruitment and Regulates Transcription In trans.Mol Cell2018
29967250Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.Clin Cancer Res2018
30150754Trac-looping measures genome structure and chromatin accessibility.Nat Methods2018
30091656Effects of human sex chromosome dosage on spatial chromosome organization.Mol Biol Cell2018
29466755Transformation of Accessible Chromatin and 3D Nucleome Underlies Lineage Commitment of Early T Cells.Immunity2018
29408376HiCTMap: Detection and analysis of chromosome territory structure and position by high-throughput imaging.Methods2018
29800151The evolution of single cell-derived colorectal cancer cell lines is dominated by the continued selection of tumor-specific genomic imbalances, despite random chromosomal instability.Carcinogenesis2018
29452566Near-tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness.FASEB J2018
29967250Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.Clin Cancer Res2018
  • 1 - 50 of 108

Recommended Authors

The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 3
Institute of Cancer Sciences, University of Glasgow
Career Start Year 2006
Number of shared co-authors 0
The National Institutes of Health
Career Start Year 2006
Number of shared co-authors 7
Michelson Center for Convergent Bioscience, University of Southern California
Career Start Year 2004
Number of shared co-authors 2
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 0
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
The Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 12
Monash University
Career Start Year 2000
Number of shared co-authors 0
The First Affiliated Hospital of Guangxi Medical University
Career Start Year 1998
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 23
Janssen Research and Development LLC
Career Start Year 1997
Number of shared co-authors 0
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 1
Ontario Institute for Cancer Research
Career Start Year 1995
Number of shared co-authors 0
University of Zurich
Career Start Year 1995
Number of shared co-authors 1
The University of MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 1
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1993
Number of shared co-authors 0
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Career Start Year 1992
Number of shared co-authors 1
The Netherlands Cancer Institute
Career Start Year 1992
Number of shared co-authors 4
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 2
University of British Columbia
Career Start Year 1988
Number of shared co-authors 2
British Columbia Cancer Research Institute
Career Start Year 1987
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 1
German Cancer Research Center (DKFZ)
Career Start Year 1986
Number of shared co-authors 2
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 2
Broad Institute
Career Start Year 1983
Number of shared co-authors 1
University of Sao Paulo
Career Start Year 1982
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 1974
Number of shared co-authors 3

Collaborators

Center for Cancer Research, National Cancer Institute
Co-authored papers 47
Universitat Autonoma de Barcelona
Co-authored papers 10
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 8
Institute of Pathology, University Medical Center Mannheim, University of Heidelberg
Co-authored papers 7
National Cancer Institute, National Institutes of Health
Co-authored papers 5
Co-authored papers 4
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Co-authored papers 4
Institut fur Pathologie, Universitatsmedizin Mannheim
Co-authored papers 3
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Vertex Pharmaceuticals
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
University of Michigan ann arbor
Co-authored papers 2
Royal Veterinary College
Co-authored papers 2
National Center for Advancing Translational Sciences
Co-authored papers 2
Co-authored papers 1
University of Southern California Keck School of Medicine
Co-authored papers 1
Co-authored papers 1
Center for Cancer Research National Cancer Institute, National Institutes of Health
Co-authored papers 1
University of Macau
Co-authored papers 1
Chalmers University of Technology
Co-authored papers 1
and Blood Institute, National Institutes of Health
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
National Cancer Institute, National Institutes of Health
Co-authored papers 1